August 22, 2025

Smoking Cessation in Cancer Care: Challenges and Opportunities

Smoking was found to worsen both cancer symptom burden and severity, and oncologic surgery may represent a unique teachable moment for smoking cessation, as patients appeared to be highly motivated to...

The ASCO Post

August 22, 2025

Does Preexisting Depression Impact Prostate Cancer Survival?

Based on the results of an analysis reported in JAMA Network Open by Zhang et al, preexisting depression is associated with an increased risk of mortality from prostate cancer.

The ASCO Post

August 21, 2025

Michael F. Chiang: Power List Perspectives

Our 2025 Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession

The Ophthalmologist

August 19, 2025

The Spirit of ASMS

For Boone Prentice, the conference was a microcosm of mass spec’s best qualities: technical brilliance, community, and optimism

The Analytical Scientist

August 18, 2025

Medicare Advantage Audits Are Expanding

Continuing its efforts to reduce fraud, waste, and abuse in Medicare, the Centers for Medicare & Medicaid Services (CMS) has announced plans to significantly enhance Risk Adjustment Data Validatio...

The ASCO Post

August 15, 2025

Is This the End of Cancer Research as We Know It?

Ongoing efforts to rein in government spending have been described as a “chainsaw for bureaucracy.” It’s an apt metaphor for the haphazard budget cuts that many federal agencies are still experiencing...

The ASCO Post

August 15, 2025

Jorge L. Alió: Power List Perspectives

Our Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession

The Ophthalmologist

August 14, 2025

Who Benefits From Vaccine Misinformation?

US vaccination rates have declined in recent years, coinciding with increased public debate over vaccine safety and policy.

KFF Health News

August 14, 2025

Surf’s Up?

New Eye study indicates water sports participants could be an overlooked risk group for AMD

The Ophthalmologist